These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20701468)

  • 61. Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.
    Moore GS; Allshouse AA; Winn VD; Galan HL; Heyborne KD
    Pregnancy Hypertens; 2015 Oct; 5(4):280-6. PubMed ID: 26597741
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation.
    Rafaeli-Yehudai T; Imterat M; Douvdevani A; Tirosh D; Benshalom-Tirosh N; Mastrolia SA; Beer-Weisel R; Klaitman V; Riff R; Greenbaum S; Alioshin A; Rodavsky Hanegbi G; Loverro G; Catalano MR; Erez O
    PLoS One; 2018; 13(7):e0200360. PubMed ID: 30001403
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight.
    Guven MA; Coskun A; Ertas IE; Aral M; Zencirci B; Oksuz H
    Hypertens Pregnancy; 2009 May; 28(2):190-200. PubMed ID: 19437229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased inflammatory biomarkers in early pregnancy is associated with the development of pre-eclampsia in patients with periodontitis: a case control study.
    Chaparro A; Sanz A; Quintero A; Inostroza C; Ramirez V; Carrion F; Figueroa F; Serra R; Illanes SE
    J Periodontal Res; 2013 Jun; 48(3):302-7. PubMed ID: 23035752
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia.
    Sugawara J; Mitsui-Saito M; Hayashi C; Hoshiai T; Senoo M; Chisaka H; Yaegashi N; Okamura K
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5329-32. PubMed ID: 15956081
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy.
    Salomon LJ; Benattar C; Audibert F; Fernandez H; Duyme M; Taieb J; Frydman R
    Am J Obstet Gynecol; 2003 Dec; 189(6):1517-22. PubMed ID: 14710054
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inflammatory markers in preeclamptic patients.
    Can M; Sancar E; Harma M; Guven B; Mungan G; Acikgoz S
    Clin Chem Lab Med; 2011 Sep; 49(9):1469-72. PubMed ID: 21913791
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of relationships between novel inflammatory markers and presence and severity of preeclampsia: Epicardial fat thickness, pentraxin-3, and neutrophil-to-lymphocyte ratio.
    Cakmak HA; Dincgez Cakmak B; Abide Yayla C; Inci Coskun E; Erturk M; Keles I
    Hypertens Pregnancy; 2017 Aug; 36(3):233-239. PubMed ID: 28569615
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia.
    Bodnar LM; Ness RB; Harger GF; Roberts JM
    Am J Epidemiol; 2005 Dec; 162(12):1198-206. PubMed ID: 16269584
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight.
    Cemgil Arikan D; Aral M; Coskun A; Ozer A
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1569-73. PubMed ID: 22185464
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serum amyloid a protein and C-reactive protein in normal pregnancy and preeclampsia.
    Kristensen K; Wide-Swensson D; Lindstrom V; Schmidt C; Grubb A; Strevens H
    Gynecol Obstet Invest; 2009; 67(4):275-80. PubMed ID: 19390201
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of cytokines as inflammatory mediators in preeclampsia.
    Udenze I; Amadi C; Awolola N; Makwe CC
    Pan Afr Med J; 2015; 20():219. PubMed ID: 26113950
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes.
    Sorokin Y; Romero R; Mele L; Wapner RJ; Iams JD; Dudley DJ; Spong CY; Peaceman AM; Leveno KJ; Harper M; Caritis SN; Miodovnik M; Mercer BM; Thorp JM; O'Sullivan MJ; Ramin SM; Carpenter MW; Rouse DJ; Sibai B
    Am J Perinatol; 2010 Sep; 27(8):631-40. PubMed ID: 20195952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.
    Hund M; Allegranza D; Schoedl M; Dilba P; Verhagen-Kamerbeek W; Stepan H
    BMC Pregnancy Childbirth; 2014 Sep; 14():324. PubMed ID: 25230734
    [TBL] [Abstract][Full Text] [Related]  

  • 75. C-reactive protein and later preeclampsia: systematic review and meta-analysis taking into account the weight status.
    Rebelo F; Schlüssel MM; Vaz JS; Franco-Sena AB; Pinto TJ; Bastos FI; Adegboye AR; Kac G
    J Hypertens; 2013 Jan; 31(1):16-26. PubMed ID: 23188419
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study.
    Molvarec A; Prohászka Z; Nagy B; Szalay J; Füst G; Karádi I; Rigó J
    J Hum Hypertens; 2006 Oct; 20(10):780-6. PubMed ID: 16761027
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.
    Adekola H; Romero R; Chaemsaithong P; Korzeniewski SJ; Dong Z; Yeo L; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2015; 28(14):1621-32. PubMed ID: 25211383
    [TBL] [Abstract][Full Text] [Related]  

  • 79. First-trimester maternal serum PP13 in the risk assessment for preeclampsia.
    Romero R; Kusanovic JP; Than NG; Erez O; Gotsch F; Espinoza J; Edwin S; Chefetz I; Gomez R; Nien JK; Sammar M; Pineles B; Hassan SS; Meiri H; Tal Y; Kuhnreich I; Papp Z; Cuckle HS
    Am J Obstet Gynecol; 2008 Aug; 199(2):122.e1-122.e11. PubMed ID: 18539259
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predictive performance of the competing risk model in screening for preeclampsia.
    Wright D; Tan MY; O'Gorman N; Poon LC; Syngelaki A; Wright A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Feb; 220(2):199.e1-199.e13. PubMed ID: 30447210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.